Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Ltd, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
Medrone Tablets 2 mg.
| Pharmaceutical Form |
|---|
|
Tablet. |
Each tablet contains 2 mg methylprednisolone.
Excipients with known effect: lactose, sucrose, colour E123 (rose colour).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Methylprednisolone |
Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. |
| List of Excipients |
|---|
|
Lactose |
High density polyethylene bottles with tamper evident caps. Each bottle contains 30 or 100 tablets.
20-25 micron hard tempered aluminium foil/lacquer, 250 micron opaque polyvinyl chloride film blister. Pack contains 30 tablets.
Not all pack sizes may be marketed.
Pfizer Ltd, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
PL 00057/1013
Date of first authorisation: 1 December 1989
Date of latest renewal: 1 February 2005
| Drug | Countries | |
|---|---|---|
| MEDRONE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
